Applied science may yield more translational research publications than basic science

While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

The NIH prioritizes funding for translational research, or studies that apply findings from basic science to promote human health and well-being. Since there are many different definitions of translational research and important milestones in biomedical research have yet to be defined, it is difficult to track and quantify its progress.

In their new study, Han and colleagues investigated the amount of translational research produced from three types of NIH-funded research awards between 2008 and 2014: basic and applied research grants in the behavioral and social sciences, and the Clinical and Translational Science Award, a program that specifically targets translational research. They analyzed all publications produced from those 6,387 awards and they determined what percentage of those publications could be classified as translational research. From this analysis, the researchers found that 3.9% of publications produced by basic research awards, 7.4% produced by applied research awards, and 13.4% of the CTSA program publications were translational.

The researchers' analysis of NIH-funded behavioral and social sciences research demonstrates a progression toward increased translational research as they moved across the research spectrum from basic science to applied science, with the targeted translational research program yielding the highest number of translational research publications. The researchers suggest that translational research can happen at any stage of research, with increasing frequency in applied science, and that targeted translational research programs such as CTSA appear to be effective at promoting the translation of basic and applied sciences into medical practices and meaningful health outcomes.

Xueying Han says: "Our findings suggest that translational research can happen at any stage along the research continuum, and that targeted translational research programs, such as the Clinical and Translational Science Award Program, appear to be effective at increasing the translation of basic and applied research to health outcomes."

Xueying Han, Sharon R Williams, Brian L Zuckerman.
A snapshot of translational research funded by the National Institutes of Health (NIH): A case study using behavioral and social science research awards and Clinical and Translational Science Awards funded publications.
PLoS ONE 13(5). doi: 10.1371/journal.pone.0196545.

Most Popular Now

Imfinzi is the first immunotherapy to demonstrate …

AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi durin...

Sandoz Healthcare Access Challenge #SandozHACk ret…

Sandoz, the Novartis generics and biosimilars division, today announces the launch of the second Sandoz Healthcare Access Challenge (HACk). The #SandozHACk is a global co...

Global survey reveals that physicians need more in…

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make inf...

In clinical trials, new antibody therapy controls …

Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers i...

Novartis licenses three novel anti-infective progr…

Novartis announced today that it has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug cand...

The Nobel Prize in Physiology or Medicine 2018 was…

Cancer kills millions of people every year and is one of humanity's greatest health challenges. By stimulating the inherent ability of our immune system to attack tumor c...

Pfizer to award more than $3 million in grants to …

Pfizer Inc. today announced the recipients of the Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Breast Cancer Research Awards. Four grants tota...

FDA approves first treatment for advanced form of …

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squam...

FDA awards 12 grants to fund new clinical trials t…

The U.S. Food and Drug Administration today announced that it has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to...

DNA islands effective as 'anti-bacterial drones'

Genomic "islands" that evolved from viruses can be converted into "drones" that disable Staphylococcus aureus, bacteria that are often resistant to antibiotics and pose a...

Addressing social and cultural drivers of type 2 d…

New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffective, unless they address social and ...

Evidence mounts linking aspirin to lower risk of o…

Taking a low-dose aspirin daily may help women lower their risk of developing ovarian cancer. A new study co-led by Moffitt Cancer Center found that women who reported ta...